BioCorRx Inc.
BICX
$0.3859
$0.059918.37%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 11.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 11.11% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | 100.00% | |||
| SG&A Expenses | 43.67% | 10.69% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.85% | 41.25% | |||
| Operating Income | -21.20% | -41.36% | |||
| Income Before Tax | -22.61% | 0.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -22.61% | 0.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 53.29% | 2,285.71% | |||
| Net Income | -22.19% | 1.58% | |||
| EBIT | -21.20% | -41.36% | |||
| EBITDA | -21.31% | -41.64% | |||
| EPS Basic | -5.98% | 8.85% | |||
| Normalized Basic EPS | 3.13% | 8.59% | |||
| EPS Diluted | -4.92% | 7.93% | |||
| Normalized Diluted EPS | 3.13% | 8.59% | |||
| Average Basic Shares Outstanding | 15.32% | 8.01% | |||
| Average Diluted Shares Outstanding | 15.32% | 8.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
